The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis
Schoeler et al.·Psychological MedicineImpact 4.3
GemischtGRADEHoch95 Zitate
Stichprobek = 88 Studien n = 10.958 Pat.
Dauerunklar
KontrolleNicht-Cannabiskonsumierende
EndpunktGedächtnisfunktion
Verblindungunklar
DesignMeta-Analyse
”Kernaussage
Cannabiskonsum war mit signifikanten Gedächtnisbeeinträchtigungen bei gesunden Personen assoziiert, aber mit verbessertem Gedächtnis bei Patienten mit psychotischen Störungen.
Zusammenfassung
Meta-Analyse über k=88 Studien (n=10.958: 7.697 Gesunde, 3.261 Psychose-Patienten) zu Cannabis-Effekten auf Gedächtnis. Bei Gesunden: Cannabis assoziiert mit Beeinträchtigungen in globalem Gedächtnis (d=0.27), prospektivem Gedächtnis (d=0.61), verbalem sofortigem (d=0.40) und verzögertem Abruf (d=0.36), visueller Erkennung (d=0.41). Bei Psychose-Patienten paradoxerweise besseres globales Gedächtnis (d=-0.11), visueller Sofortabruf (d=-0.73) und Erkennung (d=-0.42). Cannabis-nutzende Patienten waren jünger und hatten niedrigere Depressionswerte.
P
PopulationErwachsene mit und ohne Psychose, gesunde Personen (n=7.697) und Patienten mit psychotischer Störung (n=3.261)
I
InterventionCannabiskonsum (verschiedene Muster, keine Intervention im experimentellen Sinne)
C
KontrolleNicht-Cannabiskonsumierende (gesunde und psychotische Kontrollgruppen)
Background: Effect of cannabis use on memory function is a contentious issue, with effects being different in healthy individuals and patients with psychosis.
Method: Employing a meta-analytic approach we investigated the effects of cannabis use on memory function in patients with psychosis and healthy individuals, and the effect of diagnosis, memory dimension and moderating factors. A total of 88 studies were identified through a systematic literature search, investigating healthy (n = 7697) and psychotic (n = 3261) individuals. Standardized mean differences between the cannabis user and non-user groups on memory tasks were estimated using random-effects models and the effect-size statistic Cohen's d. Effects of potential moderating factors were tested using mixed-effects models and subgroup analyses.
Results: We found that cannabis use was associated with significantly (p ⩽ 0.05) impaired global (d = 0.27) and prospective memory (d = 0.61), verbal immediate (d = 0.40) and delayed (d = 0.36) recall as well as visual recognition (d = 0.41) in healthy individuals, but a better global memory (d = -0.11), visual immediate recall (d = -0.73) and recognition (d = -0.42) in patients. Lower depression scores and younger age appeared to attenuate the effects of cannabis on memory. Cannabis-using patients had lower levels of depression and were younger compared with non-using patients, whilst healthy cannabis-users had higher depression scores than age-matched non-users. Longer duration of abstinence from cannabis reduced the effects on memory in healthy and patient users.
Conclusions: These results suggest that cannabis use is associated with a significant domain-specific impairment in memory in healthy individuals but not in cannabis-using patients, suggesting that they may represent a less developmentally impaired subgroup of psychotic patients.